These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 24881122

  • 1. Preparation and stability evaluation of extemporaneous oral suspension of valsartan using commercially available tablets.
    Zaid AN, Assali M, Qaddomi A, Ghanem M, Zaaror YA.
    Int J Pharm Compd; 2014; 18(2):169-74. PubMed ID: 24881122
    [Abstract] [Full Text] [Related]

  • 2. Design, optimization, preparation and evaluation of dispersion granules of valsartan and formulation into tablets.
    Shrivastava AR, Ursekar B, Kapadia CJ.
    Curr Drug Deliv; 2009 Jan; 6(1):28-37. PubMed ID: 19418953
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Use of compounded dispersing media for extemporaneous pediatric syrups with candesartan cilexetil and valsartan.
    Musko M, Sznitowska M.
    Acta Pharm; 2014 Dec; 64(4):463-74. PubMed ID: 25531786
    [Abstract] [Full Text] [Related]

  • 6. Valsartan.
    Ardiana F, Suciati, Indrayanto G.
    Profiles Drug Subst Excip Relat Methodol; 2015 Dec; 40():431-93. PubMed ID: 26051690
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Development of valsartan-loaded gelatin microcapsule without crystal change using hydroxypropylmethylcellulose as a stabilizer.
    Li DX, Yan YD, Oh DH, Yang KY, Seo YG, Kim JO, Kim YI, Yong CS, Choi HG.
    Drug Deliv; 2010 Jul; 17(5):322-9. PubMed ID: 20367177
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetic properties and bioequivalence of 2 formulations of valsartan 160-mg tablets: A randomized, single-dose, 2-period crossover study in healthy Korean male volunteers.
    Kim JE, Ki MH, Yoon IS, Cho HJ, Kim RS, Tae Kim G, Kim DD.
    Clin Ther; 2014 Feb 01; 36(2):273-9. PubMed ID: 24529292
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Extemporaneous Compounding and Physiological Modeling of Amlodipine/Valsartan Suspension.
    Aabed WJ, Radwan AH, Zaid AN, Shraim NY.
    Int J Hypertens; 2021 Feb 01; 2021():6695744. PubMed ID: 33824764
    [Abstract] [Full Text] [Related]

  • 19. Stability of extemporaneously prepared rosuvastatin oral suspension.
    Zaid AN, Shtayah R, Qadumi A, Ghanem M, Qedan R, Daibes M, Awwad SA, Jaradat N, Kittana N.
    Am J Health Syst Pharm; 2017 Oct 01; 74(19):1579-1583. PubMed ID: 28947528
    [Abstract] [Full Text] [Related]

  • 20. Fabrication and evaluation of valsartan-polymer- surfactant composite nanoparticles by using the supercritical antisolvent process.
    Kim MS, Baek IH.
    Int J Nanomedicine; 2014 Oct 01; 9():5167-76. PubMed ID: 25404856
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.